"The Transaction is expected to yield net proceeds of $4.1 billion, representing $3.21 per share.
The indicative proceeds are net of the impact of separation costs, transaction costs,
other divestment-related costs and provisions, indicative capital gains tax, and other capital impacts.
Consistent with the approach taken in previous divestments,
the current intention is to return the majority of proceeds to shareholders"
Would shareholders' interests be better served by paying that as a cash dividend or by using that money to reduce their debt?
Interest expenses increased from $197mln in the June/22 half-year to $662mln in the Dec/22 half-year.
If those interest expenses are reduced by debt reduction,
might we expect an expansion of the P/E multiple from the current 20.7x to perhaps 23x,
more in line with peers QBE & IAG?
- Forums
- ASX - By Stock
- Ann: ACCC request for time extension
"The Transaction is expected to yield net proceeds of $4.1...
Featured News
Add SUN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.23 |
Change
0.070(0.39%) |
Mkt cap ! $23.19B |
Open | High | Low | Value | Volume |
$18.31 | $18.36 | $18.12 | $28.25M | 1.550M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6990 | $18.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.25 | 108 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6990 | 18.230 |
1 | 6991 | 18.220 |
1 | 6991 | 18.210 |
1 | 11345 | 18.190 |
1 | 2186 | 18.180 |
Price($) | Vol. | No. |
---|---|---|
18.320 | 750 | 1 |
18.330 | 15715 | 2 |
18.340 | 6991 | 1 |
18.350 | 8216 | 3 |
18.360 | 6991 | 1 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
SUN (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online